KARACHI: Dow University’s research lab has claimed today (Monday) that it has developed a vaccine for coronavirus-infected patients.
Vice-Chancellor of Dow University Professor Saeed Qureshi has said that Pakistani scientists have achieved significant success in the fight against coronavirus pandemic.
Dow University’s research team has prepared intravenous immunoglobulin (IVIG) from antibodies obtained from recovered patients of coronavirus.
Saeed Qureshi said that coronavirus patients can be treated with IVIG developed by the research team. Shaukat Ali – the principal of Dow College of Biotechnology is leading the research team.
For the first time in the world, the research team has completed the preparation of an effective immunoglobulin for the treatment of coronavirus. The treatment is safe and has been approved by the US Food and Drug Administration.
In this method, immunoglobulin is prepared after the separation of antibodies found in the blood of a recovered patient from coronavirus.
Hyper immunoglobulin obtained by laboratory testing and its safety trial on animals has been successfully stored in injection (vials). Professor Mohammad Saeed Qureshi has given the task to physicians along with the research team to devise a treatment trial strategy.
ADVERTISEMENT
